Relypsa

Pioneering advancements in cardiovascular and renal health with innovative polymeric drugs for iron deficiency and nephrology therapies.

Add To Watchlist
General Information
Company Name
Relypsa
Founded Year
2007
Location (Offices)
Founders / Decision Makers
Eric Roul - Associate Director IT Helpdesk & PMO Mary Corbett - Senior Vice President of Human Resources Patrick Treanor - President
Number of Employees
-
Industries
Biopharma, Biotechnology, Health Care
Funding Stage
Post Ipo Debt
Social Media

Relypsa - Company Profile

Relypsa is a biotech company that is pioneering advancements in cardiovascular and renal health with innovative polymeric drugs for iron deficiency and nephrology therapies. Founded in 2007, Relypsa specializes in iron deficiency, nephrology, and cardio-renal therapies within the Biopharma, Biotechnology, and Health Care industries. The company received a significant $150.00M post-IPO debt investment on 03 May 2016 from Athyrium Capital Management. Relypsa's focus on developing non-absorbed polymeric drugs for applications in cardiovascular and renal diseases demonstrates its commitment to addressing critical unmet needs in the healthcare sector.

Taxonomy: biotech, cardiovascular health, renal health, polymeric drugs, iron deficiency, nephrology, therapy, drug discovery, non-absorbed drugs, pharmaceuticals

Funding Rounds & Investors of Relypsa (10)

View All
Funding Stage Amount No. Investors Investors Date
Post-IPO Debt $150.00M 1
Athyrium Capital Management, investor in Relypsa's Post-IPO Debt round
03 May 2016
Post-IPO Equity $161.90M - 25 Feb 2015
Post-IPO Debt $35.00M 2 Silicon Valley Bank, Oxford Finance LLC 02 Jun 2014
Venture Round $2.60M 3
New Leaf Venture Partners, investor in Relypsa's Venture Round round 5AM Ventures, investor in Relypsa's Venture Round round OrbiMed, investor in Relypsa's Venture Round round
01 Oct 2012
Series C $80.00M 7
New Leaf Venture Partners, investor in Relypsa's Series C round 5AM Ventures, investor in Relypsa's Series C round OrbiMed, investor in Relypsa's Series C round Delphi Ventures, investor in Relypsa's Series C round Mediphase Venture Partners, investor in Relypsa's Series C round Sprout Group, investor in Relypsa's Series C round
Sibling Capital 		14 Aug 2012

View All 10 Funding Rounds

Latest News of Relypsa

View All

No recent news or press coverage available for Relypsa.

Similar Companies to Relypsa

View All
Hemodialysis Inc - Similar company to Relypsa
Hemodialysis Inc Pioneering comprehensive care with advanced renal dialysis solutions for enhanced quality of life.
Nutrition Direct - Similar company to Relypsa
Nutrition Direct Nutrition Direct specializes in Renal Friendly Products, as well as Wound Care, Bariatric, LTC and Oncology Products!
Model Medicines - Similar company to Relypsa
Model Medicines Building Better Medicines with AI
Innovative Renal Care - Similar company to Relypsa
Innovative Renal Care Your trusted expert and partner in kidney care
SyMap Medical - Similar company to Relypsa
SyMap Medical Crafting advanced, catheter-based systems for renal denervation therapy aimed at treating hypertension, heart failure, arrhythmia, and renal failure.
Circle Decoration Circle Decoration

Want to dive deeper into Relypsa? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now